BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28572281)

  • 1. Recurrent Stroke in Minor Ischemic Stroke or Transient Ischemic Attack With Metabolic Syndrome and/or Diabetes Mellitus.
    Chen W; Pan Y; Jing J; Zhao X; Liu L; Meng X; Wang Y; Wang Y;
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28572281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine Level Predicts Response to Dual Antiplatelet in Women With Minor Stroke or Transient Ischemic Attack: Subanalysis of the CHANCE Trial.
    Li J; Wang Y; Li H; Zuo Z; Lin J; Wang A; Zhao X; Liu L; Wang Y;
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):839-846. PubMed ID: 31941381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Metabolic Syndrome Associated with the Risk of Recurrent Stroke: A Meta-Analysis of Cohort Studies.
    Li X; Li X; Fang F; Fu X; Lin H; Gao Q
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2700-2705. PubMed ID: 29050848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized Low-Density Lipoprotein to High-Density Lipoprotein Ratio Predicts Recurrent Stroke in Minor Stroke or Transient Ischemic Attack.
    Wang A; Li S; Zhang N; Dai L; Zuo Y; Wang Y; Meng X; Wang Y
    Stroke; 2018 Nov; 49(11):2637-2642. PubMed ID: 30355199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress Hyperglycemia and Prognosis of Minor Ischemic Stroke and Transient Ischemic Attack: The CHANCE Study (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events).
    Pan Y; Cai X; Jing J; Meng X; Li H; Wang Y; Zhao X; Liu L; Wang D; Johnston SC; Wei T; Wang Y;
    Stroke; 2017 Nov; 48(11):3006-3011. PubMed ID: 29051218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack.
    Li Z; Wang Y; Zhao X; Liu L; Wang D; Wang C; Meng X; Li H; Pan Y; Wang X; Wang C; Yang X; Zhang C; Jing J; Xian Y; Johnston SC; Wang Y;
    J Am Heart Assoc; 2016 Mar; 5(3):e003038. PubMed ID: 27001965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copeptin and Long-Term Risk of Recurrent Vascular Events After Transient Ischemic Attack and Ischemic Stroke: Population-Based Study.
    Greisenegger S; Segal HC; Burgess AI; Poole DL; Mehta Z; Rothwell PM
    Stroke; 2015 Nov; 46(11):3117-23. PubMed ID: 26451023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant diabetes or hypertension with metabolic syndrome on the extent of intracranial atherosclerotic stenosis.
    Park JH; Kim BS; Ovbiagele B
    Neurol Sci; 2020 Feb; 41(2):387-395. PubMed ID: 31686244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Risk of Myocardial Infarction Compared to Recurrent Stroke After Transient Ischemic Attack and Ischemic Stroke: Systematic Review and Meta-Analysis.
    Boulanger M; Béjot Y; Rothwell PM; Touzé E
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29348322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of metabolic syndrome components and diabetes mellitus: evidence from China National Stroke Screening and Prevention Project.
    Li W; Wang D; Wang X; Gong Y; Cao S; Yin X; Zhuang X; Shi W; Wang Z; Lu Z
    BMC Public Health; 2019 Feb; 19(1):192. PubMed ID: 30764803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 1,5-Anhydroglucitol: Risk Factor of Acute Ischemic Stroke and Transient Ischemic Attack in Well-Controlled Diabetes.
    Shiga Y; Kuriyama M; Kanaya Y; Takeshima S; Takemaru M; Takamatsu K; Shimoe Y; Fujikawa Y; Nishigaki M
    Cerebrovasc Dis; 2017; 44(5-6):325-329. PubMed ID: 29073616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of metabolic syndrome on the prognosis of ischemic stroke secondary to symptomatic intracranial atherosclerosis in Chinese patients.
    Mi D; Zhang L; Wang C; Liu L; Pu Y; Zhao X; Wang Y; Wang Y
    PLoS One; 2012; 7(12):e51421. PubMed ID: 23251528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High On-Treatment Platelet Reactivity to Adenosine Diphosphate Predicts Ischemic Events of Minor Stroke and Transient Ischemic Attack.
    Rao Z; Zheng H; Wang F; Wang A; Liu L; Dong K; Zhao X; Cao Y; Wang Y
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2074-2081. PubMed ID: 28736132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial.
    Wangqin R; Wang X; Wang Y; Xian Y; Zhao X; Liu L; Li H; Meng X; Wang Y
    Stroke Vasc Neurol; 2017 Dec; 2(4):176-183. PubMed ID: 29507777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Ischemic Stroke Increases Over the Spectrum of Metabolic Syndrome Severity.
    DeBoer MD; Filipp SL; Sims M; Musani SK; Gurka MJ
    Stroke; 2020 Aug; 51(8):2548-2552. PubMed ID: 32552367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Syndrome and Risk of Ischemic Stroke in Atrial Fibrillation: ARIC Study.
    Decker JJ; Norby FL; Rooney MR; Soliman EZ; Lutsey PL; Pankow JS; Alonso A; Chen LY
    Stroke; 2019 Nov; 50(11):3045-3050. PubMed ID: 31623543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal glucose regulation increases stroke risk in minor ischemic stroke or TIA.
    Pan Y; Jing J; Li H; Wang Y; Wang Y; He Y;
    Neurology; 2016 Oct; 87(15):1551-1556. PubMed ID: 27613582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial.
    Cucchiara B; Elm J; Easton JD; Coutts SB; Willey JZ; Biros MH; Ross MA; Johnston SC
    Stroke; 2020 Mar; 51(3):792-799. PubMed ID: 32078486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
    Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
    Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CD40L Is a Useful Marker to Predict Future Strokes in Patients With Minor Stroke and Transient Ischemic Attack.
    Li J; Wang Y; Lin J; Wang D; Wang A; Zhao X; Liu L; Wang C; Wang Y;
    Stroke; 2015 Jul; 46(7):1990-2. PubMed ID: 26012640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.